vidarabine has been researched along with Kidney Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Agil, A; Al-Ahmari, A; Al-Seraihi, A; Ayas, M; Ayas, MF; Ghemlas, I | 1 |
| Hogan, JJ; Weiss, BM | 1 |
| Angelucci, E; Baronciani, D; Depau, C; Di Bartolomeo, P; Iori, AP; Mico, C; Pettinau, M; Pilo, F; Rambaldi, A; Santarone, S | 1 |
| Kersting, S; Verdonck, LF | 1 |
| Herrera, GA; Isaac, J | 1 |
| Spiers, AS | 1 |
| Imamura, T; Kadota, J; Kikuchi, H; Kohno, K; Ogata, M; Ohtsuka, E; Tomo, T | 1 |
| Cohen, P; Guillevin, L; Jarrousse, B; Lhote, F; Lortholary, O; Noël, LH; Sauvaget, F; Trépo, C | 1 |
| Leach, M; Parsons, RM; Reilly, JT; Winfield, DA | 1 |
| Ancliffe, P; Cohen, S; Griffiths, MH; Woodward, N | 1 |
2 review(s) available for vidarabine and Kidney Diseases
| Article | Year |
|---|---|
Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal Significance.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bortezomib; Cyclophosphamide; Dexamethasone; Humans; Immunoglobulins; Immunosuppressive Agents; Kidney Diseases; Lenalidomide; Melphalan; Oligopeptides; Paraproteinemias; Pentostatin; Rituximab; Thalidomide; Vidarabine | 2016 |
Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
Topics: Adenosine Deaminase Inhibitors; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Synergism; Enzyme Inhibitors; Forecasting; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Kidney Diseases; Mice; Molecular Structure; Neoplasm Proteins; Nervous System Diseases; Pentostatin; Vidarabine | 1996 |
1 trial(s) available for vidarabine and Kidney Diseases
| Article | Year |
|---|---|
Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients.
Topics: Adolescent; Adult; Aged; Busulfan; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Comorbidity; Digestive System Diseases; Feasibility Studies; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Kidney Diseases; Male; Middle Aged; Myeloablative Agonists; Prospective Studies; Reoperation; Risk; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2008 |
7 other study(ies) available for vidarabine and Kidney Diseases
| Article | Year |
|---|---|
Successful hematopoietic cell transplantation in Fanconi anemia patients with renal impairment using ultra-reduced doses of cyclophosphamide and fludarabine.
Topics: Cyclophosphamide; Fanconi Anemia; Female; Hematopoietic Stem Cell Transplantation; Humans; Kidney Diseases; Male; Transplantation Conditioning; Vidarabine | 2018 |
Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction.
Topics: Adult; Aged; Antineoplastic Agents; Cyclosporine; Disease-Free Survival; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Mycophenolic Acid; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2008 |
Cast nephropathy in a case of Waldenström's macroglobulinemia.
Topics: Aged; Biopsy; Female; Humans; Immunoglobulin A; Immunohistochemistry; Immunosuppressive Agents; Kidney Diseases; Kidney Glomerulus; Renal Dialysis; Vidarabine; Waldenstrom Macroglobulinemia | 2002 |
Successful reduced intensity allogeneic stem cell transplantation for systemic AL amyloidosis.
Topics: Adult; Amyloidosis; Diarrhea; Drug Therapy, Combination; Heart Diseases; Humans; Hypotension; Japan; Kidney Diseases; Male; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2006 |
Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis B; Hepatitis B virus; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Plasma Exchange; Polyarteritis Nodosa; Prospective Studies; Vidarabine | 1995 |
Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy.
Topics: Aged; Allantoin; Antimetabolites, Antineoplastic; Diuresis; Drug Evaluation; Female; Humans; Kidney Calculi; Kidney Diseases; Kidney Tubules; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Oliguria; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Uric Acid; Vidarabine | 1998 |
Renal myelofibrosis: an unusual cause of renal impairment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cytarabine; Granulocyte Colony-Stimulating Factor; Hematopoiesis, Extramedullary; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Primary Myelofibrosis; Vidarabine | 2000 |